The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.

the U.S. Federal Trade Commission said on Tuesday. From 2017 to 2022, the companies — UnitedHealth Group's UNH.N Optum, CVS Health's CVS.N CVS Caremark and Cigna's CI.N Express Scripts ...

Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Your medical data is not as safe as you think. Discover how a massive ransomware attack exposed millions and the key steps to ...

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...

The updated tally extends the scope beyond what was previously described by company Chief Executive Andrew Witty.

This page features the latest news about the UnitedHealth Group stock. FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down Investing.com -- Shares of CVS Health Corp (NYSE ...